U.S. rejects three stem cell patents

Apr 04, 2007

The U.S. Patent and Trademark Office has issued a preliminary rejection of three stem cell patents held by the University of Wisconsin-Madison.

The patents were rejected because the discoveries by researcher James Thomson were "obvious to one of ordinary skill," the patent office said.

The Wisconsin State Journal says the non-profit Wisconsin Alumni Research Foundation will appeal the rejection.

The patents, which cover virtually all stem cell research in the country, have brought in at least $3.2 million and "could net much more money before they expire in 2015," the newspaper said.

Companies wanting to study the cells must buy licenses costing $75,000 to $400,000. The newspaper said WARF recently started waiving the fees if the research is conducted at universities or by non-profit groups.

Critics of the patents say the fees have driven some stem cell research overseas.

Copyright 2007 by United Press International

Explore further: Sniffing out a partner at a London pheromone party

add to favorites email to friend print save as pdf

Related Stories

Advancing medicine, layer by layer

Jul 02, 2014

Personalized cancer treatments and better bone implants could grow from techniques demonstrated by graduate students Stephen W. Morton and Nisarg J. Shah, who are both working in chemical engineering professor ...

New patenting guidelines are needed for biotechnology

Apr 22, 2014

Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from Rice University's Baker Institute for Public Policy.

Recommended for you

How to win a Tour de France sprint

Jul 22, 2014

The final dash to the line in a Tour de France sprint finish may appear to the bystander to be a mess of bodies trying to cram into the width of a road, but there is a high degree of strategy involved. It ...

User comments : 0